Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 medications activate receptors in the brain and gut that regulate appetite and blood sugar, offering meaningful support for weight loss and cardiometabolic health. Originally developed for type 2 diabetes management, these compounds have been studied extensively for their ability to reduce hunger signals and improve metabolic function. PlexusDx specializes in personalized GLP-1 therapy tailored to individual genetic profiles and health goals.
How GLP-1 Medications Work in Your Body
GLP-1 (glucagon-like peptide-1) is a natural hormone your intestines release after eating. This hormone tells your brain that you're full, slows stomach emptying, and helps regulate blood sugar levels. GLP-1 receptor agonists mimic this hormone's action, creating sustained signals of satiety and reducing overall calorie intake. Clinical studies demonstrate that GLP-1 activation can decrease appetite by 30-50% in many individuals, supporting significant and sustainable weight loss outcomes.
The mechanism extends beyond simple appetite suppression. GLP-1 receptors exist throughout your central nervous system, affecting reward pathways that drive food-seeking behavior. By modulating these neural circuits, GLP-1 therapy addresses both hunger and cravings. Additionally, these medications improve insulin sensitivity and reduce hepatic glucose production, supporting overall metabolic balance independent of weight loss alone.
Clinical Applications Beyond Weight Loss
While weight management remains the primary focus for most patients, GLP-1 medications offer broader metabolic benefits. Research shows improvements in blood pressure, cholesterol profiles, and inflammation markers in individuals using these therapies. Studies have documented beneficial effects on heart health outcomes, including reduced cardiovascular events in high-risk populations. These systemic improvements reflect GLP-1's influence on multiple organ systems, not just appetite control.
GLP-1 therapy also supports improved insulin function and pancreatic beta-cell preservation in metabolically challenged individuals. Many patients report enhanced energy levels, better exercise tolerance, and improved glucose stability throughout the day. These secondary benefits often contribute significantly to long-term adherence and overall quality-of-life improvements, making GLP-1 a comprehensive metabolic intervention rather than a single-purpose medication.
Personalized GLP-1 Therapy Through Genetic Insights
Individual responses to GLP-1 therapy vary significantly based on genetic factors. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights to predict how your body may respond to different GLP-1 compounds. Key genetic variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 influence appetite regulation, receptor sensitivity, and metabolic rate. Understanding your genetic profile enables truly personalized dosing and compound selection.
The Precision Peptide test helps identify whether semaglutide, tirzepatide, or a dual-compound approach may work best for your unique peptide pathways. This genetic framework reduces trial-and-error dosing and accelerates the path to optimal results. PlexusDx adds the genetic test as a $99 add-on after your first month of treatment, allowing your clinician to refine therapy based on both your initial response and your genetic predispositions. This approach transforms GLP-1 from a one-size-fits-all medication into a precision health intervention.
PlexusDx GLP-1 Options and Accessibility
PlexusDx provides compounded GLP-1 medications from licensed 503A pharmacies across all 50 states without requiring insurance or membership fees. Compounded Semaglutide Injection starts at $149 monthly, offering a cost-effective entry point for GLP-1 therapy. Tirzepatide, a dual GIP/GLP-1 receptor agonist, begins at $249 monthly and may benefit patients seeking dual-pathway activation. All medications are HSA and FSA eligible, reducing out-of-pocket expenses for eligible individuals.
Your dose may need to go up as your body responds to therapy—but your price won't. PlexusDx pricing remains flat regardless of dose escalation, removing the financial barriers that often limit access to optimal treatment levels. Options include Injectable Semaglutide, Oral Semaglutide ($249/mo), GLP-Squared combinations ($249-$369/mo), and the Microdose GLP-1 Protocol ($129/mo) for those beginning treatment. Each option accommodates different preferences and clinical presentations, ensuring accessibility for diverse patient populations.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can GLP-1 medications help me lose weight even if I don't have diabetes?
Yes. GLP-1 receptor agonists work by suppressing appetite and improving metabolic function in anyone with excess weight, regardless of diabetes status. Clinical trials demonstrate meaningful weight loss in non-diabetic populations, with many patients experiencing 10-15% body weight reduction. PlexusDx serves patients across the metabolic spectrum, from weight loss optimization to cardiometabolic health support.
How much weight can I realistically expect to lose with GLP-1 therapy?
Individual results vary based on genetics, adherence, lifestyle, and starting weight, but clinical studies show average weight losses of 10-22% of baseline body weight over 12-24 months. Some patients achieve greater reductions with consistent dosing and supportive lifestyle changes. Your genetic profile, assessed through the Precision Peptide test, helps predict your likely response trajectory and optimal compound choice.
Is PlexusDx GLP-1 medication FDA-approved?
PlexusDx sources all GLP-1 medications from licensed 503A compounding pharmacies, which prepare customized formulations under FDA oversight and state pharmacy board regulations. While these are compounded medications rather than brand-name FDA-approved versions, they use the same active pharmaceutical ingredients manufactured under strict quality standards. All PlexusDx patients receive medications prepared by licensed compounders with rigorous quality assurance protocols.
What are the common side effects of GLP-1 therapy?
Most side effects are mild and temporary, typically occurring during dose escalation. Common experiences include nausea, decreased appetite (the intended effect), and occasional constipation, which usually resolve within days to weeks. Serious adverse events are rare but can include pancreatitis or severe dehydration. Starting with lower doses and gradual escalation minimizes side effects while maximizing therapeutic benefit.
How does the Precision Peptide Genetic Test help personalize my GLP-1 treatment?
The test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 46 additional genetic markers across 14 metabolic pathways to predict your individual response to semaglutide, tirzepatide, or dual-compound therapy. This $99 add-on after your first month enables your PlexusDx clinician to optimize your specific compound and dosing strategy based on your unique peptide biology, accelerating your path to effective treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Plate: Can You Eat Red Meat on Ozempic® and Other GLP-1 Medications?
Can You Take Spironolactone and Ozempic Together? Navigating Your Personalized Weight Loss Journey